A detailed history of Wealthspire Advisors, LLC transactions in Novavax Inc stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 20 shares of NVAX stock, worth $139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Holding current value
$139
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$6.56 - $9.71 $131 - $194
20 New
20 $0
Q2 2021

Aug 13, 2021

SELL
$121.0 - $257.67 $1.63 Million - $3.48 Million
-13,494 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$112.98 - $319.93 $1.52 Million - $4.32 Million
13,494 New
13,494 $2.45 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $545M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Wealthspire Advisors, LLC Portfolio

Follow Wealthspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.